P555 Frequent disease relapse after withdrawal of infliximab in IBD patients with sustained remission
ECCO'20 Vienna
2020
P556 Long-term probability of retreatment with anti-TNF therapy after discontinuation based on mucosal healing in inflammatory bowel disease
ECCO'20 Vienna
2020
P557 Increased risk of anastomotic leak in Crohn’s disease patients unable to complete preoperative mechanical bowel preparation
ECCO'20 Vienna
2020
P560 Incidence of joint symptoms in patients with inflammatory bowel disease on treatment with vedolizumab
ECCO'20 Vienna
2020
P561 The management of Crohn’s disease (CD) patients post ileocaecal resection: a multicentre, regional audit in Northern England
ECCO'20 Vienna
2020
P562 5-ASA in ulcerative colitis: Are they really needed in the biological therapy era?
ECCO'20 Vienna
2020
P563 Shared decision-making in pregnancy in inflammatory bowel disease: Design of a pregnancy in IBD decision aid (PIDA)
ECCO'20 Vienna
2020
P564 Psychological acceptance of surgery in patients with inflammatory bowel disease undergoing intestinal resection
ECCO'20 Vienna
2020
P568 An open-label, multicenter, phase ib, pharmacokinetic (pk) and safety study of a fimh blocker, Sibofimloc (TAK-018/EB8018), in patients with Crohn’s disease (CD)
ECCO'20 Vienna
2020
P569 The role of multidrug-resistant infections in IBD patients undergoing surgery
ECCO'20 Vienna
2020
P570 The burden of anaemia remains significant over time in patients with inflammatory bowel disease at a tertiary referral centre
ECCO'20 Vienna
2020
P571 Self-Medication with steroids in ulcerative colitis: Results of a patient survey
ECCO'20 Vienna
2020